CME's earnings engine remains transaction fees, with non-interest income exceeding 100% of total revenue through 2024-2025 and an efficiency ratio ranging 4.3%-29.0% that appears to gap exchange peers such as ICE at 38.7% and CBOE at 32.1%; 2026Q3 delivered $2.89 diluted EPS on $1.7B of revenue, a 16.1% year-over-year…
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Transaction fees remain the sole earnings driver with fee income above 100% of revenue through 2025 and reaching $1.9B in 2026Q1 before reclassifying to $319.2M in 2026Q3, while the efficiency ratio of 4.3%-29.0% signals substantial operating leverage but structural revenue volatility.
CME Group operates the world’s leading derivatives marketplace, providing critical infrastructure for futures and options across interest rates, equities, currencies, commodities, and cryptocurrencies. Its network effects mean that liquidity attracts more traders, which in turn strengthens its dominant position.
CME posted a 6.32% revenue increase in 2025, reaching $6.51 billion. The growth is driven by strong trading volumes, especially in the Market Data segment, and has resulted in record operating income and Adjusted EPS.
Geopolitical uncertainty, interest‑rate swings, and economic shifts increase market volatility, which directly benefits CME by boosting trading activity and the demand for hedging instruments.
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 21, 2026 | $3.02+1.0% vs $2.99 | $1.7B+1.3% vs $1.7B |
Q3 2026 Jul 22, 2026 | $2.99+2.7% vs $2.91 | $1.7B+1.4% vs $1.7B |
Q2 2026 Apr 22, 2026 | $3.36+0.6% vs $3.34 | $1.9B+0.3% vs $1.9B |
Q1 2026 Feb 4, 2026 | $2.77+0.7% vs $2.75 | $1.6B+0.1% vs $1.6B |
CHICAGO, Nov. 5, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a fourth-quarter dividend of $1.30 per share. The dividend is payable December 30, 2026, to shareholders of record as of December 11, 2026.
CME Group dominates the global derivatives market with industry-leading net margins. Nu is rapidly scaling its digital banking platform across Latin America with high revenue growth.
The Commodity Futures Trading Commission (CFTC), which regulates futures markets in the U.S., has recently approved stock perpetual futures. This means that contracts based on individual stocks can now begin trading for the first time on CFTC-registered exchanges.
CME Group operates a dominant global derivatives marketplace with high net margins. Interactive Brokers Group provides automated trading access to over 175 global markets.
Benchmark CME against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for CME Group Inc. (CME)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $305.89 | $109.99B | 24.93 | 7.06% | 63.92% | 16.24% | 3.57% | |
| $172.27 | $97.15B | 23.37 | 9.27% | 33.78% | 14.05% | 1.12% | |
| $353.27 | $36.97B | 24.98 | 15.31% | 28.33% | 26.84% | 0.77% | |
| $107.12 | $59.88B | 28.94 | 9.86% | 23.71% | 17.28% | 0.97% | |
| $165.59 | $5.83B | 20.00 | 3.85% | 33.87% | 23.82% | 1.89% | |
| $641.01 | $46.6B | 33.49 | 9.51% | 43.87% | — | 1.12% |
CME Group Inc. (CME) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
CME Group Inc. (CME) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 21, 2026·SEC
Sep 25, 2026·SEC
Aug 11, 2026·SEC
Get notified when CME posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CME Group Inc. (CME) stock FAQ — growth, dividends, profitability & financials explained
CME Group Inc. (CME) grew revenue by 10.6% over the trailing twelve months, compared with the twelve months before.
Yes. CME Group Inc. (CME) earned $4.40B in net income over the trailing twelve months (a 63.9% net margin).
Yes. CME Group Inc. (CME) pays a dividend that yields 3.57% at the current price, a moderate yield.
CME Group Inc. (CME) had a return on equity (ROE) of 16.2% over the trailing twelve months. That is above the market's typical 10-15%.
CME Group Inc. (CME) has a net interest margin (NIM) of -0.1%. NIM has been under pressure due to interest rate environment.
CME Group Inc. (CME) has an efficiency ratio of 21.7%. This is excellent, indicating strong cost control.
